Pharmacy price-setting boards help big business, not patients
Maryland policymakers have touted the Prescription Drug Affordability Board (PDAB) as their solution to high drug prices. Instead of tackling the root causes, these price-setting boards could exacerbate the dominance of pharmacy benefit manager (PBM) owned pharmacies at the expense of community pharmacies. PBMs are supposed to help lower patient costs but often enrich themselves at the expense of patients and community pharmacies.